This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our 隱私政策.
確認
MENU
CLOSE
language
Powerful, accessible cell therapies for patients with cancer.

We develop innovative, highly effective cell therapies for cancer that are broadly accessible for patients.
聯絡資訊
Acepodia USA
1600 Harbor Bay Parkway, Suite 140,
Alameda, CA 94502,
USA
Acepodia Taiwan
22175台灣新北市汐止區新台五路1段99號17樓之7
聯絡我們
電話: +1 (415) 366 7822 電子郵件: info@acepodiabio.com
關注我們
Copyright © 2020 Acepodia Inc.
隱私權政策 使用條款

ACC-γδ2 T

開發中產品
早期探索
前臨床
第I期
第II期
ACE1831
CD20標靶、ACC-γδ2 T細胞療法
詳細資訊
Phase I ​
ACE2016
抗EGFR、ACC-γδ2 T細胞療法
詳細資訊
Preclinical ​
ACE1708
抗PD-L1、ACC-γδ2 T細胞療法
詳細資訊
Discovery ​

ACC-oNK

開發中產品
早期探索
前臨床
第I期
第II期
ACE1702
抗HER2、ACC-oNK細胞療法
詳細資訊
Phase I ​
We have collaborated with biopharmaceutical partners and academic institutes worldwide.
聯絡我們